Aligos Therapeutics (ALGS) EPS (Diluted) (2021 - 2026)
Aligos Therapeutics (ALGS) EPS (Diluted) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.04 Bn | 130.18 Bn | 2.84 Bn | 4.31 |
| 2 | Regeneron Pharmaceuticals | 85.98 Bn | 77.98 Bn | 3.93 Bn | 12.23 |
| 3 | Argenx Se | 64.37 Bn | 59.19 Bn | 1.37 Bn | 7.33 |
| 4 | Moderna | 57.67 Bn | 52.53 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.94 Bn | 36.84 Bn | 1.53 Bn | 2.05 |
| 6 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.19 |
| 7 | BioNTech SE | 27.75 Bn | 9.35 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.24 Bn | 26.08 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.03 Bn | 26.20 Bn | - | 0.15 |
| 10 | Aligos Therapeutics | 67.90 Mn | 37.46 Mn | - | -0.14 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.14 |
| Mar 31, 2026 | -2.21 |
| Dec 31, 2025 | -2.01 |
| Sep 30, 2025 | -3.04 |
| Jun 30, 2025 | -1.53 |
| Mar 31, 2025 | 4.95 |
| Dec 31, 2024 | -13.11 |
| Sep 30, 2024 | -3.07 |
| Jun 30, 2024 | 0.81 |
| Mar 31, 2024 | -5.58 |
| Dec 31, 2023 | -10.85 |
| Sep 30, 2023 | -10.37 |
| Jun 30, 2023 | -10.87 |
| Mar 31, 2023 | -13.37 |
| Dec 31, 2022 | -12.82 |
| Sep 30, 2022 | -10.89 |
| Jun 30, 2022 | -11.67 |
| Mar 31, 2022 | -20.94 |
| Dec 31, 2021 | -22.24 |
| Sep 30, 2021 | -19.53 |